These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. Nouri-Shirazi M; Banchereau J; Bell D; Burkeholder S; Kraus ET; Davoust J; Palucka KA J Immunol; 2000 Oct; 165(7):3797-803. PubMed ID: 11034385 [TBL] [Abstract][Full Text] [Related]
32. Human invariant NKT cells are required for effective in vitro alloresponses. Patterson S; Kotsianidis I; Almeida A; Politou M; Rahemtulla A; Matthew B; Schmidt RR; Cerundolo V; Roberts IA; Karadimitris A J Immunol; 2005 Oct; 175(8):5087-94. PubMed ID: 16210612 [TBL] [Abstract][Full Text] [Related]
33. Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation. Harada K; Ihara F; Takami M; Kamata T; Mise N; Yoshizawa H; Hishiki T; Saito T; Terui K; Nakata M; Komatsu S; Ikeuchi T; Nakayama T; Yoshida H; Motohashi S Cancer Sci; 2019 Mar; 110(3):888-902. PubMed ID: 30629318 [TBL] [Abstract][Full Text] [Related]
34. Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. Larsson M; Messmer D; Somersan S; Fonteneau JF; Donahoe SM; Lee M; Dunbar PR; Cerundolo V; Julkunen I; Nixon DF; Bhardwaj N J Immunol; 2000 Aug; 165(3):1182-90. PubMed ID: 10903715 [TBL] [Abstract][Full Text] [Related]
35. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses. Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323 [TBL] [Abstract][Full Text] [Related]
36. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function. Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683 [TBL] [Abstract][Full Text] [Related]
37. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni. Mallevaey T; Zanetta JP; Faveeuw C; Fontaine J; Maes E; Platt F; Capron M; de-Moraes ML; Trottein F J Immunol; 2006 Feb; 176(4):2476-85. PubMed ID: 16456008 [TBL] [Abstract][Full Text] [Related]
38. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes. Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368 [TBL] [Abstract][Full Text] [Related]
39. CD1d and invariant NKT cells at the human maternal-fetal interface. Boyson JE; Rybalov B; Koopman LA; Exley M; Balk SP; Racke FK; Schatz F; Masch R; Wilson SB; Strominger JL Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13741-6. PubMed ID: 12368486 [TBL] [Abstract][Full Text] [Related]
40. Role of marginal zone B lymphocytes in invariant NKT cell activation. Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]